$2.48T
Total marketcap
$58.97B
Total volume
BTC 50.55%     ETH 15.18%
Dominance

Prostatype Genomics AB (publ) PROGEN.ST Stock

0.05 SEK {{ price }} -2.671758% {{change_pct}}%
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
40.2M SEK
LOW - HIGH [24H]
0.05 - 0.05 SEK
VOLUME [24H]
316.53K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-0.05 SEK

Prostatype Genomics AB (publ) Price Chart

Prostatype Genomics AB (publ) PROGEN.ST Financial and Trading Overview

Prostatype Genomics AB (publ) stock price 0.05 SEK
Previous Close 0.51 SEK
Open 0.5 SEK
Bid 0.53 SEK x N/A
Ask 0.56 SEK x N/A
Day's Range 0.5 - 0.57 SEK
52 Week Range 0.25 - 3.93 SEK
Volume 154.82K SEK
Avg. Volume 357.96K SEK
Market Cap 66.9M SEK
Beta (5Y Monthly) 0.933987
PE Ratio (TTM) N/A
EPS (TTM) -0.05 SEK
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 0.9 SEK

PROGEN.ST Valuation Measures

Enterprise Value 11.49M SEK
Trailing P/E N/A
Forward P/E -5.6
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 82.211555
Price/Book (mrq) 0.6982544
Enterprise Value/Revenue 14.118
Enterprise Value/EBITDA -0.372

Trading Information

Prostatype Genomics AB (publ) Stock Price History

Beta (5Y Monthly) 0.933987
52-Week Change -85.50%
S&P500 52-Week Change 20.43%
52 Week High 3.93 SEK
52 Week Low 0.25 SEK
50-Day Moving Average 0.48 SEK
200-Day Moving Average 1.51 SEK

PROGEN.ST Share Statistics

Avg. Volume (3 month) 357.96K SEK
Avg. Daily Volume (10-Days) 447.22K SEK
Shares Outstanding 119.46M
Float 22.61M
Short Ratio N/A
% Held by Insiders 15.00%
% Held by Institutions 13.47%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -3803.11%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -66.82%
Return on Equity (ttm) -128.73%

Income Statement

Revenue (ttm) 813.73K SEK
Revenue Per Share (ttm) 0.04 SEK
Quarterly Revenue Growth (yoy) 50.20%
Gross Profit (ttm) -12806086 SEK
EBITDA -30916224 SEK
Net Income Avi to Common (ttm) -31341608 SEK
Diluted EPS (ttm) -0.39
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 2.17M SEK
Total Cash Per Share (mrq) 0.1 SEK
Total Debt (mrq) 766.42K SEK
Total Debt/Equity (mrq) 4.18 SEK
Current Ratio (mrq) 1.093
Book Value Per Share (mrq) 0.802

Cash Flow Statement

Operating Cash Flow (ttm) -31038220 SEK
Levered Free Cash Flow (ttm) -17506356 SEK

Profile of Prostatype Genomics AB (publ)

Country Sweden
State N/A
City Solna
Address Gustaf III:s Boulevard 34
ZIP 169 73
Phone 46 08 20 87 00
Website https://www.prostatypegenomics.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 6

Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The company's test is based on database containing prostate cancer patients and provides decision support for patients and doctors when making a treatment decision. Prostatype Genomics AB (publ) was incorporated in 2007 and is based in Solna, Sweden.

Q&A For Prostatype Genomics AB (publ) Stock

What is a current PROGEN.ST stock price?

Prostatype Genomics AB (publ) PROGEN.ST stock price today per share is 0.05 SEK.

How to purchase Prostatype Genomics AB (publ) stock?

You can buy PROGEN.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Prostatype Genomics AB (publ)?

The stock symbol or ticker of Prostatype Genomics AB (publ) is PROGEN.ST.

Which industry does the Prostatype Genomics AB (publ) company belong to?

The Prostatype Genomics AB (publ) industry is Diagnostics & Research.

How many shares does Prostatype Genomics AB (publ) have in circulation?

The max supply of Prostatype Genomics AB (publ) shares is 788.29M.

What is Prostatype Genomics AB (publ) Price to Earnings Ratio (PE Ratio)?

Prostatype Genomics AB (publ) PE Ratio is now.

What was Prostatype Genomics AB (publ) earnings per share over the trailing 12 months (TTM)?

Prostatype Genomics AB (publ) EPS is -0.05 SEK over the trailing 12 months.

Which sector does the Prostatype Genomics AB (publ) company belong to?

The Prostatype Genomics AB (publ) sector is Healthcare.

Prostatype Genomics AB (publ) PROGEN.ST included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
First North All-Share DKK FIRSTNORTHDKK 97.96 DKK 14.36 USD
-0.62
First North Sweden SEK GI FNSESEKGI 1956.89 SEK 191.02 USD
-0.28
First North Sweden EUR GI FNSEEURGI 1570.14 EUR 1716.38 USD
-0.77
First North Health Care GI FN20GI 917.04 EUR 1002.44 USD
-1.17
First North All-Share EUR FIRSTNORTHEUR 97.9 EUR 107.01 USD
-0.64
First North Sweden SEK PI FNSESEKPI 1843.91 SEK 179.99 USD
-0.28
First North Sweden EUR PI FNSEEURPI 1479.5 EUR 1617.29 USD
-0.77
First North Health Care PI FN20PI 912.9 EUR 997.92 USD
-1.17
First North All-Share SEK FIRSTNORTHSEK 123.34 SEK 12.04 USD
-0.14